[以下最新消息由 OncoLock CEO 簡靜香博士 獨家提供]
Patent Content of OncoLock Co. Ltd;
豐宥科技股份有限公司
EXPRESS NEWS!!!
OncoLock Co. Ltd., has obtained the patent(s) approval of diagnosis of
"Human Ovarian Cancer" from the countries listed:
(1) European Union (17 Countries); Approval Dated 31.05.2023。
(2) Japan (Certificate No. #7023942)。
(3) Singapore (Certificate No. #11202002529T。
(4) Taiwan-ROC. (Certificate No. #1702400)
(5) China and Hong-Kong (Published)
(6) Thailand (Published)
We are looking forward to welcoming qualified Bio-Tech Global Companies
to acquire our cutting-edge technologies to transfer the marvelous "Diagnostic Techniques".
[Oct 2023, All Rights Reserved.]
https://www.youtube.com/watch?v=a8gF5ND1Wxo
Patent Content of OncoLock Co. Ltd;
豐宥科技股份有限公司
EXPRESS NEWS!!!
OncoLock Co. Ltd., has obtained the patent(s) approval of diagnosis of
"Human Ovarian Cancer" from the countries listed:
(1) European Union (17 Countries); Approval Dated 31.05.2023。
(2) Japan (Certificate No. #7023942)。
(3) Singapore (Certificate No. #11202002529T。
(4) Taiwan-ROC. (Certificate No. #1702400)
(5) China and Hong-Kong (Published)
(6) Thailand (Published)
We are looking forward to welcoming qualified Bio-Tech Global Companies
to acquire our cutting-edge technologies to transfer the marvelous "Diagnostic Techniques".
[Oct 2023, All Rights Reserved.]
https://www.youtube.com/watch?v=a8gF5ND1Wxo